CBT
Cabot Corporation
NYSE · Basic Materials · Chemicals - Specialty · US
$80.75
−0.54%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.6B | 3.7B | 4.0B | 3.9B | 4.3B |
| Cost of Revenue | 2.8B | 2.8B | 3.0B | 3.1B | 3.4B |
| Gross Profit | 832.0M | 940.0M | 960.0M | 839.0M | 885.0M |
| Operating Expenses | |||||
| R&D Expense | 55.0M | 59.0M | 63.0M | 57.0M | 55.0M |
| SG&A Expense | 277.0M | 260.0M | 283.0M | 253.0M | 258.0M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (1.0M) | — | — | 3.0M | 183.0M |
| Total Operating Expenses | 331.0M | 319.0M | 346.0M | 313.0M | 496.0M |
| Cost and Expenses | 3.1B | 3.1B | 3.4B | 3.4B | 3.9B |
| Operating Income (EBIT) | 501.0M | 621.0M | 614.0M | 526.0M | 389.0M |
| Non-Operating | |||||
| Interest Income | 29.0M | 27.0M | 32.0M | 31.0M | 11.0M |
| Interest Expense | 75.0M | 76.0M | 81.0M | 90.0M | 56.0M |
| Net Interest Income | (46.0M) | (49.0M) | (49.0M) | (59.0M) | (45.0M) |
| Other Non-Op Income/Expense | (83.0M) | (49.0M) | (79.0M) | (70.0M) | (44.0M) |
| Non-Operating Income (excl Interest) | (9.0M) | (19.0M) | 4.0M | (15.0M) | (2.0M) |
| EBT (Pre-Tax Income) | 418.0M | 572.0M | 535.0M | 456.0M | 345.0M |
| Income Tax Expense | 190.0M | 196.0M | 111.0M | (28.0M) | 102.0M |
| Bottom Line | |||||
| Net Income | 190.0M | 331.0M | 380.0M | 445.0M | 209.0M |
| Earnings from Cont. Ops | 228.0M | 376.0M | 424.0M | 484.0M | 243.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 189.0M | 331.0M | 374.0M | 437.0M | 206.0M |
| Per Share | |||||
| Basic EPS | $3.61 | $6.07 | $6.79 | $7.79 | $3.65 |
| Diluted EPS | $3.59 | $6.02 | $6.72 | $7.73 | $3.62 |
| Revenue Per Share | $70.43 | $69.14 | $73.56 | $71.16 | $76.82 |
| Shares | |||||
| Basic Shares Outstanding | 51.6M | 53.7M | 54.3M | 55.2M | 56.2M |
| Diluted Shares Outstanding | 52.0M | 54.2M | 55.7M | 56.5M | 56.9M |
| Profitability Metrics | |||||
| EBITDA | 690.0M | 794.0M | 761.0M | 685.0M | 537.0M |
| D&A | 180.0M | 154.0M | 151.0M | 144.0M | 146.0M |
| EBIT | 510.0M | 640.0M | 610.0M | 541.0M | 391.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026